LEXINGTON MEDICAL CENTER — History
CCN 420073 | 3-year financial timeline | COVID resilience: 76/100
🛡️ Public data only — no PHI permitted on this instance.
$1.4B
Latest Revenue (FY2022)
+10.8%
Revenue CAGR (3yr)
1.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $1.2B | $958M | $1.4B | +49.4% | +10.8% |
| Operating Expenses | $1.2B | $903M | $1.4B | +56.7% | +8.4% |
| Operating Margin | -3.3% | 5.7% | 1.1% | -80.0% | +0.0% |
| Net Income | $-38M | $55M | $16M | -70.2% | +0.0% |
| Licensed Beds | 508 | 527 | 541 | +2.7% | +3.2% |
| Total Patient Days | 131,019 | 100,263 | 156,301 | +55.9% | +9.2% |
| Medicare Day % | 35% | 30% | 31% | +2.8% | -6.5% |
| Medicaid Day % | 4% | 3% | 5% | +57.9% | +5.3% |
COVID Impact & Recovery
Resilience Score: 76/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +22.7% ($1.2B → $1.4B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.8%
This Hospital
+7.6%
State Avg
Latest Margin
1.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.6B | 3.4% |
| FY2024 (proj) | $1.7B | 5.6% |
| FY2025 (proj) | $1.8B | 7.8% |